Enzymotec Expands Activities in China

22 Mar 2012 --- Global biotech company commences operations in Shanghai - Local and regional customers to benefit.

22 Mar 2012 --- Enzymotec, a dynamic, biotech company and a leading global supplier of lipid-based products, announced the opening of its Shanghai office.

The new branch of Enzymotec is aimed at supporting the company's growing business activities in China as well as providing its existing customers with expert, on-hand customer service.

With a foothold in over 40 countries, Enzymotec develops and manufactures lipid-based biofunctional and nutraceutical ingredients and end products that are based on sophisticated proprietary technologies.

"This is a significant step forward for Enzymotec, which has successfully expanded its commercial activities over the last few years," says Dr. Ariel Katz, CEO of Enzymotec.  "South East Asia in general and China in particular have become key markets for us due to the economic developments in the region. In addition, we believe that maintaining a local presence is highly important and fits our global marketing strategy."

Enzymotec's innovative solutions are divided into three business segments: 

  • Infant Nutrition Division  –  Producer of InFatTM, a clinically-proven ingredient in infant formulas that mimics the fat of human milk. InFatTM is marketed through Advanced Lipids AB, a joint venture of AAK and Enzymotec. Advanced Lipids is a primary supplier of fat ingredients for leading infant formulas in China. 
  • Bioactive Division  –  A major provider of lipid-based products providing high quality solutions for the body and mind. 
  • VAYA Pharma – A researched-based, specialty pharmaceutical division dedicated to the discovery, development, manufacturing and marketing of innovative and effective, clinically tested and safe natural lipid-based medicines.

 

Enzymotec

Collapse

Who We Are

Enzymotec develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Since its establishment in 1998, the company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products. Our two business segments leverage our lipid-related expertise: Nutrition and Pharma.

Enzymotec's diverse range of products span the entire human life-cycle - from infancy to old age, providing key ingredients for use in infant formula and nutritional supplements, as well as branded medical foods.

Enzymotec's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track-record in turning advanced lipid science into commercially attractive, nutritional solutions, constantly enriching our unique cluster of technology and expertise.

What We Do

We develop clinically-validated products including bio-functional, lipid-based compounds that address a wide spectrum of growing consumer demands, such as optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases.

The comprehensive solutions we develop and manufacture are sold to major consumer companies through our global sales and marketing infrastructure.

How We Do It

We employ proprietary technologies to modify lipids harvested from natural sources, transforming these raw materials into unique and clinically-proven lipid based products. These products are familiar to the human body and possess beneficial secondary characteristics, such as extended shelf life and improved scent or taste profile.

Our Source of Competitive Advantage:

• Safe and clinically-proven products supported by proprietary technology and R&D expertise.

• Experienced leadership and scientific advisory boards.

• Diversified business model

• Strong customer relationships and partnerships

• Integrated scalable platform and product offering, based on state-of-the-art production capabilities.

Related Articles

Business News

Unilever to sell Spreads business to KKR private equity for €6.825 bn

16 Dec 2017 --- Unilever has received a binding offer from KKR to purchase its global Spreads business for €6.825 billion on a cash-free, debt-free basis. Unilever’s Spreads business includes brands such as Becel, Flora, Country Crock, Blue Band, I Can’t Believe It’s Not Butter, Rama and ProActiv. It operates across 66 countries around the world. In 2016 the business had a turnover of €3,032 million, EBITDA (before any carveout adjustments under new ownership) of €680 million, and assets of €1,108 million. This announcement, including the information contained in this release, excludes the South Africa Spreads business. 

Regulatory News

LCI and Novolyze partner up to strengthen on the safety of flour products

15 Dec 2017 --- Limagrain Céréales Ingredients (LCI) has recently partnered with Novolyze to reinforce the microbiological control of its proprietary heat process for flours: Farigel. In order to confirm the effectiveness of the Farigel process, LCI chose to use the innovative products developed by Novolyze. The methodology utilizes harmless bacteria that mimic the behavior of foodborne pathogens under different kinds of stress. 

Business News

Givaudan opens new business solutions center in Kuala Lumpur

15 Dec 2017 --- Givaudan has announced the official opening of its new Givaudan Business Solutions (GBS) delivery center in Kuala Lumpur, Malaysia. The center will be the home to the business services and solutions that will form a platform for the Company's growth in the Asia Pacific region.

Food Ingredients News

New Naturex CSO: “A mere fraction of the plant kingdom’s potential has been explored”

15 Dec 2017 --- Last month, leader in natural specialty ingredients, Naturex announced changes to its senior management team with the appointment of Sarah Martin as its new Chief Scientific Officer (CSO). Martin, who has a wealth of high-level experience in the food science and nutrition industry, joins Naturex’s Executive committee, taking global responsibility for Naturex’s scientific and innovation programs.

Business News

Firmenich expands presence in Africa by acquiring Flavourome

14 Dec 2017 --- Firmenich has announced that it is acquiring Flavourome, an established privately-held flavors company in South Africa that has been successfully serving the local market since 1998. With this acquisition, Firmenich will accelerate business growth in this strategic region by gaining direct access to new customers, while operating its own high performing manufacturing facility in South Africa. 

More Articles